January 18, 2021January 18, 2021
Sjögren’s Foundation Favors COVID-19 Vaccination for Patients
News
The Sjögren’s Foundation is recommending that people with Sjögren’s syndrome ages 16 and older be vaccinated against COVID-19 infection, ... Read more
January 4, 2021January 4, 2021
Health, Financial Impact of Acute Kidney Injury Similar With or Without Sjögren’s
News
In-hospital mortality, the length of a hospital stay, and hospitalization charges for people with acute kidney injury and Sjögren’s ... Read more
December 22, 2020January 11, 2021
Electrical Brain Stimulation Found to Safely Reduce Sjogren’s Fatigue
News
A technique that delivers low electric currents to stimulate specific parts of the brain can safely reduce fatigue in ... Read more
December 21, 2020December 21, 2020
Higher Risk of Blood Clots With COVID-19 Infection Seen in Study
News
People with Sjögren’s syndrome and other systemic autoimmune rheumatic diseases (SARDs) may be at a greater risk of severe ... Read more
December 14, 2020December 14, 2020
RSLV-132 Lowers Fatigue in Primary Sjögren’s Patients in Phase 2 Trial
News
RSLV-132, an investigational treatment for autoimmune conditions, led to significant and clinically meaningful reductions in patient-reported fatigue in people ... Read more
December 7, 2020December 7, 2020
Study Links Altered Gut Microbiome in Sjogren’s to Systemic Inflammation
News
Primary Sjogren’s syndrome (pSS) patients have less diversity in their gut microbiome — with less abundant beneficial bacteria but ... Read more
November 30, 2020November 30, 2020
Sjogren’s Foundation Welcomes Applications for 2021 Research Grants
News
Applications for a next round of Sjögren’s Foundation research grants are being accepted from U.S. investigators working to better ... Read more
November 26, 2020November 25, 2020
New $100M Program Aims to Improve Diversity in Clinical Trials
News, syndicated
A new $100-million program aims to improve the diversity of participants in U.S. clinical trials with the ultimate goal of ... Read more
November 23, 2020November 23, 2020
Sjogren’s Burden Determined by Organ Involvement, Fatigue, Pain, Study Suggests
News
Primary Sjögren’s syndrome (pSS) syndrome can be classified based on the extent of organ involvement, fatigue, and pain, with ... Read more
November 16, 2020November 16, 2020
LO2A Drops Lessen Dry Eye Symptoms, Even Outperform Systane on Some Measures
News
Wize Pharma‘s LO2A eye drops result in clinically meaningful improvements in dry eye signs and symptoms in people with Sjögren’s ... Read more
November 9, 2020November 9, 2020
Hydroxychloroquine Lowers Cardiovascular Risk in Sjögren’s Patients, Study Suggests
News
Long-term use of hydroxychloroquine significantly lowers the risk of coronary artery disease, the most common form of heart disease, in ... Read more
November 2, 2020November 2, 2020
Study Links Immune Regulatory Molecule NEAT1 to Primary Sjogren’s
News
An immune regulatory molecule known as NEAT1 is produced at greater levels in the immune T-cells of people with ... Read more

January 18, 2021January 18, 2021

Sjögren’s Foundation Favors COVID-19 Vaccination for Patients

News

The Sjögren’s Foundation is recommending that people with Sjögren’s syndrome ages 16 and older be vaccinated against COVID-19 infection, and advices patients to talk with their healthcare provider about ... Read more

January 4, 2021January 4, 2021

Health, Financial Impact of Acute Kidney Injury Similar With or Without Sjögren’s

News

In-hospital mortality, the length of a hospital stay, and hospitalization charges for people with acute kidney injury and Sjögren’s syndrome are no different from those without Sjögren’s, a large-scale ... Read more

December 22, 2020January 11, 2021

Electrical Brain Stimulation Found to Safely Reduce Sjogren’s Fatigue

News

A technique that delivers low electric currents to stimulate specific parts of the brain can safely reduce fatigue in people with primary Sjogren’s syndrome (pSS), a pilot study has ... Read more

December 21, 2020December 21, 2020

Higher Risk of Blood Clots With COVID-19 Infection Seen in Study

News

People with Sjögren’s syndrome and other systemic autoimmune rheumatic diseases (SARDs) may be at a greater risk of severe complications from COVID-19 than people without these disorders, a study ... Read more

December 14, 2020December 14, 2020

RSLV-132 Lowers Fatigue in Primary Sjögren’s Patients in Phase 2 Trial

News

RSLV-132, an investigational treatment for autoimmune conditions, led to significant and clinically meaningful reductions in patient-reported fatigue in people with primary Sjögren’s syndrome, results from a Phase 2 clinical trial ... Read more

December 7, 2020December 7, 2020

Study Links Altered Gut Microbiome in Sjogren’s to Systemic Inflammation

News

Primary Sjogren’s syndrome (pSS) patients have less diversity in their gut microbiome — with less abundant beneficial bacteria but more abundant opportunistic bacteria with pro-inflammatory activity — compared with ... Read more

November 30, 2020November 30, 2020

Sjogren’s Foundation Welcomes Applications for 2021 Research Grants

News

Applications for a next round of Sjögren’s Foundation research grants are being accepted from U.S. investigators working to better understand Sjögren’s syndrome, a chronic immune system disorder, and improve patients’ ... Read more

November 26, 2020November 25, 2020

New $100M Program Aims to Improve Diversity in Clinical Trials

News, syndicated

A new $100-million program aims to improve the diversity of participants in U.S. clinical trials with the ultimate goal of achieving better health outcomes and parity in care for underserved ... Read more

November 23, 2020November 23, 2020

Sjogren’s Burden Determined by Organ Involvement, Fatigue, Pain, Study Suggests

News

Primary Sjögren’s syndrome (pSS) syndrome can be classified based on the extent of organ involvement, fatigue, and pain, with symptoms varying substantially from patient to patient, a new study ... Read more

November 16, 2020November 16, 2020

LO2A Drops Lessen Dry Eye Symptoms, Even Outperform Systane on Some Measures

News

Wize Pharma‘s LO2A eye drops result in clinically meaningful improvements in dry eye signs and symptoms in people with Sjögren’s syndrome, topline results from an exploratory Phase 4 trial show. ... Read more